Figure 4From: The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceEvaluation of the response of Tumor #2 to increasing doses of gemcitabine. A. Control; B. Tumors in mice treated with 1.0 mg/kg gemcitabine grow at a rate comparable to that of untreated tumors; C. Tumors in mice treated with 1.5 mg/kg gemicitabine show growth inhibition to varying degrees (p = .045); D. Tumors in mice treated with 2.5 mg/kg gemcitabine alone show uniform suppression (p < .001).Back to article page